Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GMDA

Gamida Cell (GMDA) Stock Price, News & Analysis

Gamida Cell logo

About Gamida Cell Stock (NASDAQ:GMDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.40
52-Week Range
N/A
Volume
23.04 million shs
Average Volume
9.20 million shs
Market Capitalization
$5.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

GMDA Stock News Headlines

July 4th: 59% dividend from Bitcoin (No Crypto Needed)
I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Yes, you read that right. And no, you don't need to buy any cryptocurrency or trade options... Here's the deal: Our July 4th special includes a FREE report on what I call the "Bitcoin Income Vault."
Q4 2023 Gamida Cell Ltd Earnings Call
Why Gamida Cell Shares Are Falling Today
See More Headlines

GMDA Stock Analysis - Frequently Asked Questions

Gamida Cell Ltd. (NASDAQ:GMDA) announced its earnings results on Monday, August, 14th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.13.

Gamida Cell (GMDA) raised $50 million in an initial public offering (IPO) on Friday, October 26th 2018. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO and Needham & Company Oppenheimer & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gamida Cell investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Bank of America (BAC), JPMorgan Chase & Co. (JPM), Zomedica (ZOM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/14/2023
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GMDA
Fax
N/A
Employees
143
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63 million
Pretax Margin
-3,531.17%

Debt

Sales & Book Value

Annual Sales
$1.78 million
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
N/A

Miscellaneous

Free Float
143,699,000
Market Cap
$5.04 million
Optionable
Optionable
Beta
0.93
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:GMDA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners